Fresenius Medical Care Introduces WetAlert™ Wireless Wetness Detector Designed to Prevent Blood Loss During Home Dialysis

Fresenius Medical Care Introduces WetAlert™ Wireless Wetness Detector Designed to Prevent Blood Loss During Home Dialysis

WALTHAM, Mass.--(BUSINESS WIRE)-- Fresenius Medical Care (NYSE: FMS  ) , the world’s largest provider of dialysis products and services, announced today its introduction of the WetAlert wireless wetness detector, designed to detect venous needle displacement and prevent blood loss for dialysis patients at home. The WetAlert transmitter is the only device in the U.S. market that senses moisture at the venous needle site and sets off a process to automatically stop the blood pump, close the venous clamp, display a visual alarm, and sound an audible alarm. The device transmits radio signals directly to the 2008K@home machine. It is unique and highly effective in design, and reusable for up to six months.

Venous needle dislodgement (VND) is a potential, serious complication related to dialysis therapy. If the venous needle becomes dislodged or disconnected from the patient’s vascular access, it could cause the patient to hemmorhage.

“The WetAlert wireless wetness detector is a brand new option that may help reduce the fear of blood leaks during home dialysis because the blood pump stops on the 2008K@home machine, thereby decreasing the amount of potential blood loss if VND occurs,” said Dr. Jose Diaz-Buxo, MD, FACP, Chief Medical Officer at Fresenius Medical Care. Recently, the U.S. Food and Drug Administration (FDA) cleared the WetAlert wireless wetness detector for use.

About Fresenius Medical Care North America

Through our leading network of more than 2,100 dialysis facilities in North America and our vascular access centers, laboratory, pharmacy and affiliated hospitals and nephrology practices, Fresenius Medical Care provides renal services to hundreds of thousands of people throughout the United States, Mexico and Canada. We are also the continent's top producer of dialysis equipment, dialyzers and related disposable products and a major supplier of renal pharmaceuticals. For more information about the company, visit; for information about patient services, visit

Legal Disclaimer:

This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including changes in business, economic and competitive conditions, regulatory reforms, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.

Indications for Use: The Fresenius 2008K@home is indicated for acute and chronic dialysis therapy in an acute or chronic facility. The 2008K@home is also intended for hemodialysis in the home and must be observed by a trained and qualified person as prescribed by their physician. The WetAlert wireless wetness detector is indicated for use with the Fresenius 2008K@home hemodialysis machine and is an optional accessory to aid in the detection of blood and water leaks during hemodialysis. Home hemodialysis using the detector must be observed by a trained and qualified person as prescribed by their physician.

Caution: Federal (US) law restricts this device to sale by or on the order of a physician or other licensed practitioner. For safe and proper use of this device refer to the device Instructions for Use.

Media contact:
Fresenius Medical Care
Jon Stone, 1-781-699-9704 / voice
Company contact:
Fresenius Medical Care
Terri Bonadio, 1-704-488-5562 / voice

KEYWORDS:   United States  North America  Massachusetts


Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2247201, ~/Articles/ArticleHandler.aspx, 3/30/2015 10:12:19 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...